Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have shown encouraging treatment efficacy for metastatic breast cancer in several clinical trials. However, response only occurred in a small population. Evidence predicting response and survival of patients with metastatic breast cancer following ICI...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Yutian, Zou, Xuxiazi, Zheng, Shaoquan, Tang, Hailin, Zhang, Lijuan, Liu, Peng, Xie, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436841/
https://www.ncbi.nlm.nih.gov/pubmed/32874208
http://dx.doi.org/10.1177/1758835920940928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436841/
https://www.ncbi.nlm.nih.gov/pubmed/32874208
http://dx.doi.org/10.1177/1758835920940928

Ejemplares similares